Condition: Pre-diabetes · Sponsor: ICE S.p.A.
7-Ketolithocholic Acid, a naturally occurring bile acid, is a novel food currently under investigation for potential metabolic benefits, including glucose-lowering effects. This study aims to evaluate the efficacy and safety of 7-Ketolithocholic Acid, administered alongside a low-glycaemic, hypocaloric diet, and increased physical activity in reducing fasting plasma glucose and other metabolic parameters in subjects with prediabetes. Demonstrating a clinically meaningful glucose-lowering effect would support its potential role in early intervention to prevent or delay the onset of type 2 diabetes.
This description comes directly from the study's public registry record.
Dr. Riccardo Agati · +33 (0)184636817 · riccardo.agati@gmail.com
Always discuss trial participation with your own doctor first.
| Studio Medico, Piazza Eroi della Libertà, 7 | Bordighera, Italy | Recruiting |
| Studio Medico, Via Roma, 46 | Ospedaletti, Italy | Recruiting |
| Studio Medico, Via Elba 21 | San Bartolomeo al Mare, Italy | Recruiting |
| Studio Medico, Corso Imperatrice 5 | Sanremo, Italy | Recruiting |
| Studio Medico, Corso Imperatrice 5 | Sanremo, Italy | Recruiting |
| Studio Medico, Corso Matuzia 13 | Sanremo, Italy | Recruiting |
| Studio Medico, Via Galileo Galilei 475 | Sanremo, Italy | Recruiting |
| Studio Medico, Via Galileo Galilei 475 | Sanremo, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07650123